Financials Ambalal Sarabhai Enterprises Limited

Equities

AMBALALSA6

INE432A01017

Pharmaceuticals

Delayed Bombay S.E. 04:54:50 2024-05-08 am EDT 5-day change 1st Jan Change
48.29 INR +11.94% Intraday chart for Ambalal Sarabhai Enterprises Limited +4.64% +27.01%

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 815.4 1,095 1,460 1,353 2,675 1,572
Enterprise Value (EV) 1 1,112 1,352 1,640 1,485 2,687 1,739
P/E ratio 63.8 x 26 x 10.4 x 4.61 x 5.67 x 14.2 x
Yield - - - - - -
Capitalization / Revenue 0.65 x 0.72 x 1.09 x 0.82 x 1.35 x 0.91 x
EV / Revenue 0.89 x 0.89 x 1.23 x 0.9 x 1.36 x 1.01 x
EV / EBITDA -10.7 x 14.2 x 345 x 21 x 9.54 x 14.3 x
EV / FCF -7.08 x 14.7 x -5.79 x -10.1 x -11.3 x -8.82 x
FCF Yield -14.1% 6.79% -17.3% -9.88% -8.86% -11.3%
Price to Book 3.07 x 3.58 x 3.26 x 1.83 x 2.23 x 1.2 x
Nbr of stocks (in thousands) 76,633 76,633 76,633 76,633 76,633 76,633
Reference price 2 10.64 14.29 19.05 17.65 34.90 20.51
Announcement Date 8/14/18 8/7/19 9/8/20 9/1/21 8/30/22 9/6/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 1,250 1,519 1,335 1,652 1,975 1,721
EBITDA 1 -103.8 95.22 4.76 70.74 281.8 121.3
EBIT 1 -123.9 74.8 -14.41 52.84 264.7 100.4
Operating Margin -9.91% 4.93% -1.08% 3.2% 13.4% 5.84%
Earnings before Tax (EBT) 1 79.64 82.13 149.4 325.4 541.9 148.3
Net income 1 12.77 42.49 140.6 293.6 472.2 111
Net margin 1.02% 2.8% 10.53% 17.77% 23.91% 6.45%
EPS 2 0.1666 0.5500 1.830 3.830 6.160 1.449
Free Cash Flow 1 -157.1 91.79 -283.3 -146.6 -238 -197.1
FCF margin -12.57% 6.04% -21.22% -8.88% -12.05% -11.45%
FCF Conversion (EBITDA) - 96.4% - - - -
FCF Conversion (Net income) - 216.02% - - - -
Dividend per Share - - - - - -
Announcement Date 8/14/18 8/7/19 9/8/20 9/1/21 8/30/22 9/6/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 297 257 180 132 12.8 167
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -2.862 x 2.7 x 37.81 x 1.866 x 0.0456 x 1.379 x
Free Cash Flow 1 -157 91.8 -283 -147 -238 -197
ROE (net income / shareholders' equity) 4.93% 14.9% 37.3% 49.5% 48.7% 8.85%
ROA (Net income/ Total Assets) -4.26% 2.24% -0.45% 1.67% 7.51% 2.64%
Assets 1 -300 1,898 -31,297 17,622 6,288 4,211
Book Value Per Share 2 3.460 4.000 5.840 9.640 15.60 17.10
Cash Flow per Share 2 1.760 2.220 1.670 1.920 1.580 1.320
Capex 1 116 104 38.1 24.6 157 207
Capex / Sales 9.24% 6.84% 2.86% 1.49% 7.95% 12.01%
Announcement Date 8/14/18 8/7/19 9/8/20 9/1/21 8/30/22 9/6/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. AMBALALSA6 Stock
  4. Financials Ambalal Sarabhai Enterprises Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW